The primary endpoint was the proportion of participants achieving any weight loss during follow-up
The pharmacodynamic endpoints were change from baseline to end of treatmentdefined as 1 week after the last dosein body weight, fasting plasma glucose (FPG), and other fasting glucose metabolism parameters (insulin, C-peptide, glucagon, and pro-insulin)
( D ) Quantification of intra- and extracellular melanin content by spectrophotometry at 405 nm from pMCs cultured 72 h on substrates of varying stiffness (soft, intermediate or stiff) coated with COL IV, COL I or FN
doi: 10.1158/1078-0432.CCR-12-0343 6 ElderDEBarnhilRBastianBCCookMGde la FouchardireAGeramiPet al
Proper storage maintains the medications potency
Some may determine that non-stimulant ADHD medications are more appropriate in such cases, even if they prove less effective for symptom control